Literature DB >> 27418535

Endoscopic Endonasal Transsphenoidal Surgery, A Reliable Method for Treating Primary and Recurrent/Residual Craniopharyngiomas: Nine Years of Experience.

Ercan Bal1, Kamil Öge2, Mustafa Berker2.   

Abstract

OBJECTIVE: Craniopharyngioma resection is one of the most challenging surgical procedures. Herein, we describe our extended endoscopic endonasal transsphenoidal surgery (EETS) technique, and the results of 9 years of use on primary and recurrent/residual craniopharyngiomas.
METHODS: This study reviewed 28 EETSs in 25 patients with craniopharyngiomas between January 2006 and September 2015. The patients were divided into 2 groups, newly diagnosed patients (group A, n = 15), and patients having residual or recurrent tumors (group B, n = 10). There was no significant difference between the groups in terms of the largest tumor diameter (P = 0.495), and all patients underwent EETS. The clinical and ophthalmologic examinations, imaging studies, endocrinologic studies, and operative findings for these cases were reviewed retrospectively.
RESULTS: The number of gross total resections in group A was 13/15, and 7/10 in group B. Three of the patients developed postoperative cerebrospinal fluid leakage (all in group A). There were no neurovascular or ophthalmologic complications, and no meningitis or mortality was observed.
CONCLUSIONS: There has been a notable increase in the use of EETS in the treatment of craniopharyngiomas during the last decade. Despite its increased use in the treatment of primary craniopharyngiomas, its implementation for recurrent or residual craniopharyngiomas has been viewed with suspicion. In this study, the results have been presented separately for primary and recurrent/residual craniopharyngiomas, so that the results can be compared. Overall, EETS is a reliable and successful surgical treatment method for primary and recurrent/residual craniopharyngiomas.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Craniopharyngioma; Endocrinology; Endoscopic technique; Ophthalmology; Primary; Recurrent; Residual

Mesh:

Year:  2016        PMID: 27418535     DOI: 10.1016/j.wneu.2016.07.004

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  3 in total

1.  Treatment of Cystic Craniopharyngiomas: An Update.

Authors:  Federico Bianchi; Alberto Benato; Luca Massimi
Journal:  Adv Tech Stand Neurosurg       Date:  2022

2.  Surgical Outcomes of Endoscopic Endonasal Surgery in 29 Patients with Craniopharyngioma.

Authors:  Arad Iranmehr; Mostafa Esmaeilnia; Khashayar Afshari; Seyed Mousa Sadrehosseini; Azin Tabari; Morteza Faghih Jouibari; Mehdi Zeinalizadeh
Journal:  J Neurol Surg B Skull Base       Date:  2020-06-19

Review 3.  Association of histological subtype with risk of recurrence in craniopharyngioma patients: a systematic review and meta-analysis.

Authors:  Jie Wu; Xiao Wu; You Qing Yang; Han Ding; Le Yang; You Yuan Bao; Lin Zhou; Chen Xing Yang; Tao Hong
Journal:  Neurosurg Rev       Date:  2021-06-22       Impact factor: 2.800

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.